*Vivimed Labs (Rs 183.1): Buy * **
** ** ** ** ** ** ** ** Investors with short-term trading perspective can consider buying the stock of Vivimed Labs. It is seen from the charts of the stock that it has been on a steady long-term uptrend from its November 2009 low of Rs 32. Both medium- as well as short-term trend is also up for the stock. In April 2010, the stock emphatically broke through its significant long-term resistance at Rs 150, which at a later stage provided support. On Wednesday the stock gained almost three per cent and closed well above its immediate resistance of Rs 178 levels. There is an increase in volume over the past two trading sessions. The stock is trading way above its 21- and 50-day moving averages. The daily and weekly relative strength indices are featuring in the bullish zone. Moreover, the daily moving average convergence divergence has also signalled a buy. Considering that the stock's medium-term uptrend line is intact, we are positive on the stock. We expect it to move up until it hits our price target of Rs 190 or Rs 194 in the forthcoming trading session. Short-term traders can buy the stock while maintaining stop-loss at Rs 178. Yoganand D http://www.thehindubusinessline.com/2010/07/08/stories/2010070853211100.htm -- You received this message because you are subscribed to the Google Groups ""GLOBAL SPECULATORS"" group. To post to this group, send email to [email protected]. To unsubscribe from this group, send email to [email protected]. For more options, visit this group at http://groups.google.com/group/globalspeculators?hl=en.
